Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
News
Wang Luo
2024,08,23
Continuously deepening and refining market and brand promotion, Cheng Yi Pharmaceutical's revenue in the first half of the year increased by 10.89% year-on-year
Data Treasure
2024,08,21
List of long-term heavy holdings of social security funds exposed
Popular Securities News
2024,08,21
Cheng Yi Pharmaceutical: Strong Core Product Power, Revenue Increased by 10.89% YoY in the First Half of the Year
Cheng Yi
Company notice
Company news
Media coverage
2019,11,04
Be a good "liaison" and convey a "good voice"
2019,10,21
Sincere Pharmaceutical won the "Best Growth Potential Listed Company" award
2019,10,17
Full coverage of 'Party managed talents'
2019,08,01
The President of the Municipal Health Promotion Association led a team to visit Cheng Yi
2019,07,17
Cheng Yi's First Ranking in China's Top 100 Pharmaceutical Industry
2019,06,22
Cheng Yi Pharmaceutical's Stable Operation and Growth Promise
2019,06,04
Introducing high-end talents to add impetus to enterprise development
2019,04,03
Strive to become a practitioner of high-quality development for private enterprises
2019,03,09
Deploy new tasks and move towards a new era
2019,03,01
Cheng Yi Pharmaceutical achieved a successful start in multiple tasks
2019,02,20
Cheng Yi Pharmaceutical is moving towards a 1 billion yuan scale enterprise
2019,01,16
One of the founders of the company, Chu Fude, passed away and donated his body
<
1
...
8
9
10
...
16
>
Contact Us
view more